PT - JOURNAL ARTICLE AU - Yang, Wen-Chi AU - Chen, Ya-Fang AU - Yang, Chi-Cheng AU - Wu, Pei-Fang AU - Chan, Hsing-Min AU - Chen, Jenny Ling-Yu AU - Chen, Guann-Yiing AU - Cheng, Jason Chia-Hsien AU - Kuo, Sung-Hsin AU - Hsu, Feng-Ming TI - Hippocampal Avoidance Whole-brain Radiotherapy in Preservation of Neurocognitive Function for Brain Metastases: A Phase II Blinded Randomized Trial AID - 10.1101/2020.04.29.20080234 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.29.20080234 4099 - http://medrxiv.org/content/early/2020/06/25/2020.04.29.20080234.short 4100 - http://medrxiv.org/content/early/2020/06/25/2020.04.29.20080234.full AB - Background Hippocampal avoidance whole-brain radiotherapy (HA-WBRT) shows potential for neurocognitive preservation. This study aimed to evaluate whether HA-WBRT or conformal WBRT is better for preserving neurocognitive function.Methods This single-blinded randomized phase II trial enrolled patients with brain metastases and randomly assigned to receive HA-WBRT or conformal WBRT. Primary end point is the decline of Hopkins Verbal Learning Test–Revised (HVLT-R) Delayed Recall at 4 months after treatment. Neurocognitive function tests were analyzed with a mixed effect model. Brain progression free survival (BPFS) and overall survival (OS) were estimated using the Kaplan–Meier method.Results Patients were enrolled from March 2015 to December 2018 with a median follow-up of 12.4 months. A total of 70 patients were randomized. No differences in baseline neurocognitive function existed between the two arms. There were no differences in any neurocognitive assessments at four months. At six months, patients receiving HA-WBRT showed favorable perpetuation of HVLT-R total recall (mean difference = 2.60, p = 0.079) and significantly better preservation of the HVLT-R recognition-discrimination index (mean difference = 1.78, p = 0.019) and memory score (mean difference = 4.38, p = 0.020) compared with patients undergoing conformal WBRT. There were no differences in TMT part A, part B, or the COWA test between the two arms at any time point. There were no differences in BPFS or OS between arms as well.Conclusions Patients receiving HA-WBRT without Memantine showed better preservation in late verbal memory, but not in verbal fluency or executive function.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02393131Funding StatementThis work was partially supported by the National Taiwan University Hospital, Yunlin Branch, Yunlin, Taiwan (NTUHYL 108.S004 to WCY) and the Ministry of Science and Technology, Executive Yuan, Taipei, Taiwan (MOST 107-2314-B-002-098 to FMH).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the institutional research ethics committee and was independently monitored by the institutional clinical trial center at National Taiwan University Hospital.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available on request. The data underlying this article will be shared on reasonable request to the corresponding author.